Louise Lang Lehrskov

Louise Lang Lehrskov

Auto-generated profile, based on publicly available information

Louise Lang Lehrskov

Center for Physical Activity Research (CFAS), Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Cell Metabolism
Verified
Journal Article
Closed access
AWAnne-Sophie Wedell-Neergaard
Anne-Sophie Wedell-Neergaard
LLLouise Lang Lehrskov
Louise Lang Lehrskov
RCRegitse Højgaard Christensen
Regitse Højgaard Christensen
GLGrit Elster Legaard
Grit Elster Legaard
EDEmma Dorph
Emma Dorph
RKRikke Krogh-Madsen
Rikke Krogh-Madsen

1 June 2018 in Cell Metabolism
Verified
Journal Article
Closed access
LLLouise Lang Lehrskov
Louise Lang Lehrskov
MLMark Lyngbaek
Mark Lyngbaek
LSLine Soederlund
Line Soederlund
GLGrit Elster Legaard
Grit Elster Legaard
JEJan Adam Ehses
Jan Adam Ehses
EHEllingsgaard Helga
Ellingsgaard Helga

17 May 2019 in Seminars in Immunopathology
Verified
Journal Article
Closed access
PDF file
LLLouise Lang Lehrskov
Louise Lang Lehrskov
RCRegitse Højgaard Christensen
Regitse Højgaard Christensen

3 April 2023 in Acta Oncologica
Verified
Journal Article
Closed access
JMJoan M. Màrmol
Joan M. Màrmol
MCMichala Carlsson
Michala Carlsson
SRSteffen H. Raun
Steffen H. Raun
MGMia K. Grand
Mia K. Grand
JSJonas Sørensen
Jonas Sørensen
LSLykke Sylow
Lykke Sylow
Insulin resistance is a critical cause of metabolic dysfunctions. Metabolic dysfunction is common in patients with cancer and is associated with higher cancer recurrence rates and reduced overall s...

1 August 2019 in JAMA Cardiology
Verified
Journal Article
Closed access
RCRegitse Højgaard Christensen
Regitse Højgaard Christensen
AWAnne-Sophie Wedell-Neergaard
Anne-Sophie Wedell-Neergaard
LLLouise Lang Lehrskov
Louise Lang Lehrskov
GLGrit Elster Legaard
Grit Elster Legaard
EDEmma Dorph
Emma Dorph
HEHelga Ellingsgaard
Helga Ellingsgaard
Epicardial and pericardial adipose tissues are emerging as important risk factors for cardiovascular disease, and there is a growing interest in discovering strategies to reduce the accumulation of fat in these depots. To investigate whether a 12-week endurance or resistance training intervention regulates epicardial and pericardial adipose tissue mass. Secondary analysis of a randomized, assessor-blinded clinical trial initiated on August 2016 and completed April 2018. This single-center, community-based study included 50 physically inactive participants with abdominal obesity. Participants were randomized to a supervised high-intensity interval endurance training (3 times a week for 45 minutes), resistance training (3 times a week for 45 minutes), or no exercise (control group). Change in epicardial and pericardial adipose tissue mass assessed by magnetic resonance imaging, based on a prespecified secondary analysis plan including 3 of 5 parallel groups. Of 50 participants (mean [SD] age, 41 [14] years, 10 men [26%]; mean [SD] body mass index [calculated as weight in kilograms divided by height in meters squared], 32 [5]), 39 [78%] completed the study. Endurance training and resistance training reduced epicardial adipose tissue mass by 32% (95% CI, 10%-53%) and 24% (95% CI, 1%-46%), respectively, compared with the no exercise control group (56% [95% CI, 24%-88%]; P = .001 and 48% [95% CI, 15%-81%]; P < .001, respectively). While there was a nonsignificant reduction in pericardial adipose tissue mass after endurance training (11% [95% CI, -5% to 27%]; P = .17), resistance training significantly reduced pericardial adipose tissue mass by 31% (95% CI, 16%-47%; P < .001) when compared with the no exercise control group. Compared with the no exercise control group, there was an increase in left ventricular mass by endurance (20 g [95% CI, 11%-30%]; P < .001) and resistance training (18 g [95% CI, 8%-28%]; P < .001). Other cardiometabolic outcomes remained unchanged after the 12-week trial period. In individuals with abdominal obesity, both endurance and resistance training reduced epicardial adipose tissue mass, while only resistance training reduced pericardial adipose tissue mass. These data highlight the potential preventive importance of different exercise modalities as means to reduce cardiac fat in individuals with abdominal obesity. ClinicalTrials.gov identifier: NCT02901496.

12 November 2019 in Circulation
Verified
Journal Article
Closed access
PDF file
RCRegitse Højgaard Christensen
Regitse Højgaard Christensen
LLLouise Lang Lehrskov
Louise Lang Lehrskov
AWAnne-Sophie Wedell-Neergaard
Anne-Sophie Wedell-Neergaard
GLGrit Elster Legaard
Grit Elster Legaard
MRMathias Ried-Larsen
Mathias Ried-Larsen
JRJaya Birgitte Rosenmeier
Jaya Birgitte Rosenmeier